Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.906 |
High Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.8912 |
High Similarity |
NPD1549 |
Phase 2 |
0.891 |
High Similarity |
NPD3749 |
Approved |
0.8903 |
High Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.8844 |
High Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.8844 |
High Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.8839 |
High Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.8831 |
High Similarity |
NPD7411 |
Suspended |
0.8808 |
High Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.8766 |
High Similarity |
NPD4380 |
Phase 2 |
0.8718 |
High Similarity |
NPD7819 |
Suspended |
0.8716 |
High Similarity |
NPD2344 |
Approved |
0.8707 |
High Similarity |
NPD1510 |
Phase 2 |
0.8696 |
High Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.8693 |
High Similarity |
NPD920 |
Approved |
0.8671 |
High Similarity |
NPD7075 |
Discontinued |
0.8649 |
High Similarity |
NPD2796 |
Approved |
0.8625 |
High Similarity |
NPD6959 |
Discontinued |
0.8608 |
High Similarity |
NPD7768 |
Phase 2 |
0.8606 |
High Similarity |
NPD6559 |
Discontinued |
0.86 |
High Similarity |
NPD2800 |
Approved |
0.8599 |
High Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.8562 |
High Similarity |
NPD5494 |
Approved |
0.8562 |
High Similarity |
NPD642 |
Clinical (unspecified phase) |
0.8562 |
High Similarity |
NPD1240 |
Approved |
0.8535 |
High Similarity |
NPD1934 |
Approved |
0.8491 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.8487 |
Intermediate Similarity |
NPD2309 |
Approved |
0.8477 |
Intermediate Similarity |
NPD1243 |
Approved |
0.8446 |
Intermediate Similarity |
NPD1607 |
Approved |
0.8438 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.8431 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.8365 |
Intermediate Similarity |
NPD2801 |
Approved |
0.8355 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.8323 |
Intermediate Similarity |
NPD2533 |
Approved |
0.8323 |
Intermediate Similarity |
NPD2534 |
Approved |
0.8323 |
Intermediate Similarity |
NPD2532 |
Approved |
0.8302 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.8258 |
Intermediate Similarity |
NPD1511 |
Approved |
0.8258 |
Intermediate Similarity |
NPD6799 |
Approved |
0.8253 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.8242 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.8242 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.8242 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.8232 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.8204 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.8193 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.8182 |
Intermediate Similarity |
NPD3750 |
Approved |
0.8182 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.8176 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.8171 |
Intermediate Similarity |
NPD1247 |
Approved |
0.8153 |
Intermediate Similarity |
NPD1512 |
Approved |
0.8148 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.8118 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.8105 |
Intermediate Similarity |
NPD2343 |
Clinical (unspecified phase) |
0.8095 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.8092 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.8054 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.8049 |
Intermediate Similarity |
NPD919 |
Approved |
0.8039 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.8039 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.8 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.7988 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.7975 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7941 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7935 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.7933 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7933 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.7919 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7888 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7882 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7871 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7866 |
Intermediate Similarity |
NPD2296 |
Approved |
0.7857 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7857 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.7843 |
Intermediate Similarity |
NPD6651 |
Approved |
0.7841 |
Intermediate Similarity |
NPD4287 |
Approved |
0.7836 |
Intermediate Similarity |
NPD7472 |
Approved |
0.7834 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7824 |
Intermediate Similarity |
NPD7893 |
Clinical (unspecified phase) |
0.7799 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.7798 |
Intermediate Similarity |
NPD5711 |
Approved |
0.7798 |
Intermediate Similarity |
NPD5710 |
Approved |
0.7798 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7791 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7764 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7758 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7746 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7744 |
Intermediate Similarity |
NPD6280 |
Approved |
0.7744 |
Intermediate Similarity |
NPD6279 |
Approved |
0.7722 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7701 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7701 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.7697 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7692 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7692 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7688 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7687 |
Intermediate Similarity |
NPD1547 |
Clinical (unspecified phase) |
0.7687 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.7667 |
Intermediate Similarity |
NPD4360 |
Phase 2 |
0.7667 |
Intermediate Similarity |
NPD4363 |
Phase 3 |
0.7643 |
Intermediate Similarity |
NPD1471 |
Phase 3 |
0.764 |
Intermediate Similarity |
NPD5401 |
Approved |
0.764 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.763 |
Intermediate Similarity |
NPD1729 |
Discontinued |
0.7624 |
Intermediate Similarity |
NPD4361 |
Phase 2 |
0.7624 |
Intermediate Similarity |
NPD4362 |
Clinical (unspecified phase) |
0.761 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.76 |
Intermediate Similarity |
NPD1203 |
Approved |
0.7597 |
Intermediate Similarity |
NPD943 |
Approved |
0.759 |
Intermediate Similarity |
NPD5761 |
Phase 2 |
0.759 |
Intermediate Similarity |
NPD5760 |
Phase 2 |
0.7588 |
Intermediate Similarity |
NPD6808 |
Phase 2 |
0.7582 |
Intermediate Similarity |
NPD3764 |
Approved |
0.7576 |
Intermediate Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.7566 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.7561 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.755 |
Intermediate Similarity |
NPD2798 |
Approved |
0.7546 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7528 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7516 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7516 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.7468 |
Intermediate Similarity |
NPD3268 |
Approved |
0.7459 |
Intermediate Similarity |
NPD7501 |
Clinical (unspecified phase) |
0.7459 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7458 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7458 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7438 |
Intermediate Similarity |
NPD2654 |
Approved |
0.7415 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.7414 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.74 |
Intermediate Similarity |
NPD9717 |
Approved |
0.7391 |
Intermediate Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.7391 |
Intermediate Similarity |
NPD7003 |
Approved |
0.7368 |
Intermediate Similarity |
NPD2797 |
Approved |
0.7358 |
Intermediate Similarity |
NPD5408 |
Approved |
0.7358 |
Intermediate Similarity |
NPD5404 |
Approved |
0.7358 |
Intermediate Similarity |
NPD5406 |
Approved |
0.7358 |
Intermediate Similarity |
NPD5405 |
Approved |
0.7349 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7348 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7326 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7325 |
Intermediate Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.7325 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.7325 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.7325 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7299 |
Intermediate Similarity |
NPD2403 |
Approved |
0.7299 |
Intermediate Similarity |
NPD4575 |
Clinical (unspecified phase) |
0.7296 |
Intermediate Similarity |
NPD4308 |
Phase 3 |
0.7285 |
Intermediate Similarity |
NPD3972 |
Approved |
0.7283 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7278 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.7273 |
Intermediate Similarity |
NPD2861 |
Phase 2 |
0.7267 |
Intermediate Similarity |
NPD2424 |
Discontinued |
0.7261 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7261 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7256 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7255 |
Intermediate Similarity |
NPD1164 |
Approved |
0.7255 |
Intermediate Similarity |
NPD1470 |
Approved |
0.7247 |
Intermediate Similarity |
NPD3658 |
Clinical (unspecified phase) |
0.7241 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.724 |
Intermediate Similarity |
NPD8151 |
Discontinued |
0.7235 |
Intermediate Similarity |
NPD4288 |
Approved |
0.7226 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.7225 |
Intermediate Similarity |
NPD7584 |
Approved |
0.7219 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.7219 |
Intermediate Similarity |
NPD6844 |
Discontinued |
0.7219 |
Intermediate Similarity |
NPD37 |
Approved |
0.7216 |
Intermediate Similarity |
NPD7177 |
Discontinued |
0.7215 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7215 |
Intermediate Similarity |
NPD1933 |
Approved |
0.7209 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7205 |
Intermediate Similarity |
NPD6006 |
Clinical (unspecified phase) |
0.7205 |
Intermediate Similarity |
NPD6005 |
Phase 3 |
0.7205 |
Intermediate Similarity |
NPD6003 |
Clinical (unspecified phase) |
0.7205 |
Intermediate Similarity |
NPD6002 |
Phase 3 |
0.7205 |
Intermediate Similarity |
NPD6004 |
Phase 3 |
0.7193 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7193 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7193 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7188 |
Intermediate Similarity |
NPD651 |
Clinical (unspecified phase) |
0.7182 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7181 |
Intermediate Similarity |
NPD9545 |
Approved |
0.7181 |
Intermediate Similarity |
NPD6777 |
Approved |
0.7181 |
Intermediate Similarity |
NPD6781 |
Approved |
0.7181 |
Intermediate Similarity |
NPD6780 |
Approved |
0.7181 |
Intermediate Similarity |
NPD6778 |
Approved |
0.7181 |
Intermediate Similarity |
NPD6776 |
Approved |
0.7181 |
Intermediate Similarity |
NPD6779 |
Approved |
0.7181 |
Intermediate Similarity |
NPD6782 |
Approved |
0.7171 |
Intermediate Similarity |
NPD1608 |
Approved |
0.7161 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.716 |
Intermediate Similarity |
NPD5889 |
Approved |
0.716 |
Intermediate Similarity |
NPD5890 |
Approved |
0.7159 |
Intermediate Similarity |
NPD3446 |
Phase 1 |
0.7151 |
Intermediate Similarity |
NPD6104 |
Discontinued |
0.7143 |
Intermediate Similarity |
NPD3266 |
Approved |
0.7143 |
Intermediate Similarity |
NPD3267 |
Approved |
0.7134 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7134 |
Intermediate Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.7124
|
Intermediate Similarity |
NPD4749 |
Approved |